Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07487246 · ClinicalTrials.gov registry record · Phase 2
Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement
A Phase 2 study, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 76
- Enrollment target
NCT07487246 is a Phase 2 study that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 76 participants.
The verdict
NCT07487246, a Phase 2 study, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.
Interventions
- DRUG Placebo
- DRUG Ketorolac
- DRUG Saline
- DRUG oral ibuprofen
- DRUG Lidocaine HCl 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2026-06-29 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07487246
The ClinicalTrials.gov registry entry for NCT07487246 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT07487246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07487246 about?
NCT07487246 is a clinical study titled "Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement". The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.
What is the current status of trial NCT07487246?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 76 participants. The study started on 2026-06-29. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07487246?
The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG), Saline (DRUG), oral ibuprofen (DRUG), Lidocaine HCl 1% (DRUG).
Who is sponsoring clinical trial NCT07487246?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.